Pathophysiology of glutamine and glutamate metabolism in premature infants

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 1, 2007, Pages 75-79

  Neu, Josef ^a,b   Li, Nan ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Critical illness; Glutamate; Glutamine; Inflammation; Intestine; Neonate

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; HEAT SHOCK PROTEIN;

AMINO ACID METABOLISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; CLINICAL TRIAL; CRITICAL ILLNESS; GASTROINTESTINAL TRACT; HUMAN; IMMUNOMODULATION; INFLAMMATION; METABOLIC DISORDER; NEWBORN; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PREMATURITY; REVIEW;

BACTERIAL TRANSLOCATION; CLINICAL TRIALS; CRITICAL ILLNESS; GLUTAMIC ACID; GLUTAMINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION;

EID: 33845437230     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328011923c     Document Type: Review

References (32)

1. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001; 16:393-402.
2. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001; 29:2075-2080.
3. Coeffier M, Marion R, Leplingard A, et al. Glutamine decreased interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins E2 production by human gut in-vitro. Cytokine 2002; 18:92-97.
4. Houdijk AP, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma [see comments]. Lancet 1998; 352:772-776.
5. Neu J, Roig JC, Meetze WH, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 1997; 131:691-699.
6. Li N, Liboni K, Fang MZ, et al. Glutamine decreases lipopolysaccharide- induced intestinal inflammation in infant rats. Am J Physiol Gastrointest Liver Physiol 2004; 286:G914-G921.
7. Wischmeyer PE. Can glutamine turn off the motor that drives systemic inflammation? Crit Care Med 2005; 33:1175-1178.
8. Thomas S, Prabhu R, Balasubramanian KA. Surgical manipulation of the intestine and distant organ damage - protection by oral glutamine supplementation. Surgery 2005; 137:48-55.
9. Humbert B, Nguyen P, Martin L, et al. Effect of glutamine on glutathione kinetics in vivo in dogs. J Nutr Biochem 2006. doi:10.1016/j.jnutbio.2006.02. 002. An evaluation of glutathione kinetics and how they are altered by GLN availability.
10. Li N, Lewis P, Samuelson D, et al. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2004; 287:G726-G733.
11. Liboni KC, Li N, Scumpia PO, et al. Glutamine modulates LPS-induced IL-8 production through IκB/NF-κB in human fetal and adult intestinal epithelium. J Nutr 2005; 135:245-251.
12. Hubert-Buron A, Leblond J, Jacquot A, et al. Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaBalpha ubiquitination. J Nutr 2006; 136:1461-1465. An in-depth study of the intracellular mechanisms of GLN-mediated downregulation of the inflammatory response in intestinal epithelium.
13. Evans ME, Jones DP, Ziegler TR. Glutamine inhibits cytokine-induced apoptosis in human colonic epithelial cells via the pyrimidine pathway. Am J Physiol Gastrointest Liver Physiol 2005; 289:G388-G396.
14. Singleton KD, Wischmeyer PE. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 2006; 25:295-299. Provides mechanisms of how GLN might benefit patients with burns and other forms of heat-related stresses.
15. Dhaliwal R, Heyland DK. Nutrition and infection in the intensive care unit: what does the evidence show? Curr Opin Crit Care 2005; 11:461-467.
16. Kreymann KG, Berger MM, Deutz NEP, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006; 25:210-223. This review is of importance because it points to guidelines for use of GLN in certain subpopulations of adults. The same could be applicable to certain subpopulations of premature infants.
17. Zhou YP, Jiang ZM, Sun YH, et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind,controlledclinical trial. J Parenter Enteral Nutr 2003;27:241-245.
18. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281:G216-G228.
19. Peng X, Yan H, You Z, et al. Clinical and protein metabolic efficacy of glutamine granules-supplemented enteral nutrition in severely burned patients. Burns 2005; 31:342-346.
20. Vaughn P, Thomas P, Clark R, et al. Enteral glutamine supplementation and morbidity in low birthweight infants. J Pediatr 2003; 142:662-668.
21. Parimi PS, Kadrofske MM, Gruca LL, et al. Amino acids, glutamine, and protein metabolismin very low birth weight infants. Pediatr Res 2005; 58:1259-1264.
22. Kalhan SC, Parimi PS, Gruca LL, et al. Glutamine supplement with parenteral nutrition decreases whole body proteolysis in low birth weight infants. J Pediatr 2005; 146:642-647.
23. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants. Am J Clin Nutr 2003; 77:737-743.
24. Van den Berg A, Van Elburg RM, Westerbeek EA, et al. Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. Am J Clin Nutr 2005; 81:1397-1404.
25. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, et al. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 2004; 64:4858-4869.
26. Abcouwer SF, Marjon PL, Loper RK, et al. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci 2002; 43:2791-2798.
27. Neu J. Functional development of the fetal gastrointestinal tract. Semin Perinatol 1989; 13:224-235.
28. Neu J, Afzal A, Pan H, et al. The dipeptide arg-GLN inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2006; 47:3151-3155. First reported study in animals of the arginyl-GLN dipeptide showing potential benefit against oxygen-induced proliferative retinopathy.
29. Tubman TRJ, Thompson SW, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2006; 3: CD001457. A review of some of the trials of GLN supplementation in preterm infants with the suggestion that additional trials should not be a research priority.
30. Neu J. Glutamine supplements in premature infants: why and how. J Pediatr Gastroenterol Nutr 2003; 37:533-535.
31. Coeffier M, Le Pessot F, Leplingard A, et al. Acute enteral glutamine infusion enhances heme oxygenase-1 expression in human duodenal mucosa. J Nutr 2002; 132:2570-2573.
32. Le Bacquer O, Laboisse C, Darmaun D. Glutamine preserves protein synthesis and paracellular permeability in Caco-2 cells submitted to 'luminal fasting'. Am J Physiol Gastrointest Liver Physiol 2003; 285:G128-G136.